First Edition - Vol. 1, n.1 (2020)
05/25/2020
One of the review articles is the Analysis of Expansion Mesenchymal Stromal in Patients with low risk myelodysplastic Syndrome.
The study aims to evaluate the expansion of mesenchymal stromal cells (MSCs) and the expression of p53 protein in patients with SMD, low risk, according to the International Prognostic System (IPSS), in order to demonstrate the importance of these evaluations also diagnostics.
